APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inhalation General Anesthesia Drugs Industry Growth and Trends Forecast to 2032

27 December 202594 pages

Choose your research edition.

Industry ResearchInhalation General Anesthesia Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation General Anesthesia Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Inhalation General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation General Anesthesia Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation General Anesthesia Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Inhalation General Anesthesia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation General Anesthesia Drugs include AbbVie, Baxter, LAB UNKNOWN, Maruishi, Piramal, PT Novell Pharmaceutical, Viatris and Hengrui, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inhalation General Anesthesia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhalation General Anesthesia Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhalation General Anesthesia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhalation General Anesthesia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inhalation General Anesthesia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhalation General Anesthesia Drugs Market by Company

AbbVie

Baxter

LAB UNKNOWN

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

Hengrui

Inhalation General Anesthesia Drugs Segment by Type

Isoflurane

Sevoflurane

Other

Inhalation General Anesthesia Drugs Segment by Application

Hospital

Clinic

Other

Inhalation General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inhalation General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Isoflurane Table 2. Major Company of Sevoflurane Table 3. Major Company of Other Table 4. Global Inhalation General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Inhalation General Anesthesia Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Inhalation General Anesthesia Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Inhalation General Anesthesia Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Inhalation General Anesthesia Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Inhalation General Anesthesia Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Inhalation General Anesthesia Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Inhalation General Anesthesia Drugs Industry Trends Table 26. Inhalation General Anesthesia Drugs Industry Drivers Table 27. Inhalation General Anesthesia Drugs Industry Opportunities and Challenges Table 28. Inhalation General Anesthesia Drugs Industry Restraints Table 29. Global Inhalation General Anesthesia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Inhalation General Anesthesia Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Inhalation General Anesthesia Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Inhalation General Anesthesia Drugs Sales Share by Company (2021-2026) Table 33. Global Inhalation General Anesthesia Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Inhalation General Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Inhalation General Anesthesia Drugs Major Company Production Sites and Headquarters Table 36. Global Inhalation General Anesthesia Drugs Company, Product Type & Application Table 37. Global Inhalation General Anesthesia Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Inhalation General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Inhalation General Anesthesia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Inhalation General Anesthesia Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Inhalation General Anesthesia Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Inhalation General Anesthesia Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Inhalation General Anesthesia Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Inhalation General Anesthesia Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Inhalation General Anesthesia Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Inhalation General Anesthesia Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Inhalation General Anesthesia Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Inhalation General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Inhalation General Anesthesia Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Inhalation General Anesthesia Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Inhalation General Anesthesia Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Inhalation General Anesthesia Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Inhalation General Anesthesia Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Inhalation General Anesthesia Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. AbbVie Company Information Table 73. AbbVie Business Overview Table 74. AbbVie Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AbbVie Inhalation General Anesthesia Drugs Product Portfolio Table 76. AbbVie Recent Development Table 77. Baxter Company Information Table 78. Baxter Business Overview Table 79. Baxter Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Baxter Inhalation General Anesthesia Drugs Product Portfolio Table 81. Baxter Recent Development Table 82. LAB UNKNOWN Company Information Table 83. LAB UNKNOWN Business Overview Table 84. LAB UNKNOWN Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio Table 86. LAB UNKNOWN Recent Development Table 87. Maruishi Company Information Table 88. Maruishi Business Overview Table 89. Maruishi Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Maruishi Inhalation General Anesthesia Drugs Product Portfolio Table 91. Maruishi Recent Development Table 92. Piramal Company Information Table 93. Piramal Business Overview Table 94. Piramal Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Piramal Inhalation General Anesthesia Drugs Product Portfolio Table 96. Piramal Recent Development Table 97. PT Novell Pharmaceutical Company Information Table 98. PT Novell Pharmaceutical Business Overview Table 99. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio Table 101. PT Novell Pharmaceutical Recent Development Table 102. Viatris Company Information Table 103. Viatris Business Overview Table 104. Viatris Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Viatris Inhalation General Anesthesia Drugs Product Portfolio Table 106. Viatris Recent Development Table 107. Hengrui Company Information Table 108. Hengrui Business Overview Table 109. Hengrui Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hengrui Inhalation General Anesthesia Drugs Product Portfolio Table 111. Hengrui Recent Development Table 112. North America Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 114. North America Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 115. North America Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Inhalation General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 117. North America Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Inhalation General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Inhalation General Anesthesia Drugs Market Share by Country (2021-2026) Table 120. North America Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Inhalation General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 122. Europe Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 124. Europe Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 125. Europe Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Inhalation General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Inhalation General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Inhalation General Anesthesia Drugs Market Share by Country (2021-2026) Table 130. Europe Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Inhalation General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Inhalation General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Inhalation General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Inhalation General Anesthesia Drugs Market Share by Country (2021-2026) Table 140. Asia-Pacific Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Inhalation General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 142. Latin America Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 144. Latin America Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 145. Latin America Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Inhalation General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Inhalation General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Inhalation General Anesthesia Drugs Market Share by Country (2021-2026) Table 150. Latin America Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Inhalation General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Inhalation General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Inhalation General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Inhalation General Anesthesia Drugs Market Share by Country (2021-2026) Table 160. Middle East and Africa Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Inhalation General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Inhalation General Anesthesia Drugs Distributors List Table 165. Inhalation General Anesthesia Drugs Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Inhalation General Anesthesia Drugs Image Figure 2. Global Inhalation General Anesthesia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation General Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation General Anesthesia Drugs Sales (2021-2032) & (K Units) Figure 5. Isoflurane Image Figure 6. Global Isoflurane Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sevoflurane Image Figure 8. Global Sevoflurane Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Inhalation General Anesthesia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Inhalation General Anesthesia Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Inhalation General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Inhalation General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Inhalation General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Inhalation General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Inhalation General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Inhalation General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Inhalation General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Inhalation General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Inhalation General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Inhalation General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Inhalation General Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Inhalation General Anesthesia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Inhalation General Anesthesia Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Inhalation General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Inhalation General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Inhalation General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Inhalation General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Inhalation General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Inhalation General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Inhalation General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Inhalation General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Inhalation General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Inhalation General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Inhalation General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Inhalation General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Inhalation General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Inhalation General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Inhalation General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Inhalation General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Inhalation General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Inhalation General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Inhalation General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Inhalation General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Inhalation General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Inhalation General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Inhalation General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Inhalation General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Inhalation General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Inhalation General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Inhalation General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Inhalation General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Inhalation General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Inhalation General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Inhalation General Anesthesia Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Inhalation General Anesthesia Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Sevoflurane
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AbbVie
  • Baxter
  • LAB UNKNOWN
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • Hengrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation General Anesthesia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inhalation General Anesthesia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inhalation General Anesthesia Drugs Market by Type
  6. 1.3.1 Isoflurane
  7. 1.3.2 Sevoflurane
  8. 1.3.3 Other
  9. 1.4 Global Inhalation General Anesthesia Drugs Market Size by Type
  10. 1.4.1 Global Inhalation General Anesthesia Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Inhalation General Anesthesia Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Inhalation General Anesthesia Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Inhalation General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Inhalation General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Inhalation General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Inhalation General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Inhalation General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inhalation General Anesthesia Drugs Industry Trends
  2. 2.2 Inhalation General Anesthesia Drugs Industry Drivers
  3. 2.3 Inhalation General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Inhalation General Anesthesia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inhalation General Anesthesia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Inhalation General Anesthesia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Inhalation General Anesthesia Drugs Price (2021-2026)
  4. 3.4 Global Inhalation General Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation General Anesthesia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Inhalation General Anesthesia Drugs Company, Product Type & Application
  7. 3.7 Global Inhalation General Anesthesia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation General Anesthesia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation General Anesthesia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
4 Inhalation General Anesthesia Drugs Regional Status and Outlook
  1. 4.1 Global Inhalation General Anesthesia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inhalation General Anesthesia Drugs Historic Market Size by Region
  3. 4.2.1 Global Inhalation General Anesthesia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inhalation General Anesthesia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inhalation General Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inhalation General Anesthesia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Inhalation General Anesthesia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inhalation General Anesthesia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inhalation General Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhalation General Anesthesia Drugs by Application
  1. 5.1 Inhalation General Anesthesia Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Inhalation General Anesthesia Drugs Market Size by Application
  6. 5.2.1 Global Inhalation General Anesthesia Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Inhalation General Anesthesia Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Inhalation General Anesthesia Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Inhalation General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Inhalation General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Inhalation General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Inhalation General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Inhalation General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Inhalation General Anesthesia Drugs Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Inhalation General Anesthesia Drugs Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 LAB UNKNOWN
  14. 6.3.1 LAB UNKNOWN Company Information
  15. 6.3.2 LAB UNKNOWN Business Overview
  16. 6.3.3 LAB UNKNOWN Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio
  18. 6.3.5 LAB UNKNOWN Recent Developments
  19. 6.4 Maruishi
  20. 6.4.1 Maruishi Company Information
  21. 6.4.2 Maruishi Business Overview
  22. 6.4.3 Maruishi Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Maruishi Inhalation General Anesthesia Drugs Product Portfolio
  24. 6.4.5 Maruishi Recent Developments
  25. 6.5 Piramal
  26. 6.5.1 Piramal Company Information
  27. 6.5.2 Piramal Business Overview
  28. 6.5.3 Piramal Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Piramal Inhalation General Anesthesia Drugs Product Portfolio
  30. 6.5.5 Piramal Recent Developments
  31. 6.6 PT Novell Pharmaceutical
  32. 6.6.1 PT Novell Pharmaceutical Company Information
  33. 6.6.2 PT Novell Pharmaceutical Business Overview
  34. 6.6.3 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio
  36. 6.6.5 PT Novell Pharmaceutical Recent Developments
  37. 6.7 Viatris
  38. 6.7.1 Viatris Company Information
  39. 6.7.2 Viatris Business Overview
  40. 6.7.3 Viatris Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Viatris Inhalation General Anesthesia Drugs Product Portfolio
  42. 6.7.5 Viatris Recent Developments
  43. 6.8 Hengrui
  44. 6.8.1 Hengrui Company Information
  45. 6.8.2 Hengrui Business Overview
  46. 6.8.3 Hengrui Inhalation General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hengrui Inhalation General Anesthesia Drugs Product Portfolio
  48. 6.8.5 Hengrui Recent Developments
7 North America by Country
  1. 7.1 North America Inhalation General Anesthesia Drugs Sales by Country
  2. 7.1.1 North America Inhalation General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inhalation General Anesthesia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inhalation General Anesthesia Drugs Market Size by Country
  6. 7.2.1 North America Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inhalation General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inhalation General Anesthesia Drugs Sales by Country
  2. 8.1.1 Europe Inhalation General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inhalation General Anesthesia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inhalation General Anesthesia Drugs Market Size by Country
  6. 8.2.1 Europe Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inhalation General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inhalation General Anesthesia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Inhalation General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inhalation General Anesthesia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inhalation General Anesthesia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inhalation General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inhalation General Anesthesia Drugs Sales by Country
  2. 10.1.1 South America Inhalation General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inhalation General Anesthesia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inhalation General Anesthesia Drugs Market Size by Country
  6. 10.2.1 South America Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inhalation General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inhalation General Anesthesia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Inhalation General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inhalation General Anesthesia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inhalation General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inhalation General Anesthesia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Inhalation General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inhalation General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inhalation General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inhalation General Anesthesia Drugs Value Chain Analysis
  2. 12.1.1 Inhalation General Anesthesia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inhalation General Anesthesia Drugs Production Mode & Process
  7. 12.2 Inhalation General Anesthesia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inhalation General Anesthesia Drugs Distributors
  10. 12.2.3 Inhalation General Anesthesia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst